Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001401914-21-000067
Filing Date
2021-04-20
Accepted
2021-04-20 16:04:25
Documents
1
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_161894903590649.html 3  
1 FORM 3 wf-form3_161894903590649.xml 3 1668
  Complete submission text file 0001401914-21-000067.txt   3259
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Issuer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1270 AVE OF THE AMERICAS 7TH FL - 1026 NEW YORK NY 10020
Business Address
Ononye-Onyia Sophia Nnenna (Reporting) CIK: 0001857183 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36395 | Film No.: 21837866